I

Immunome, Inc.

42 employees

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biotechnology
immunotherapy
Medical
antigen discovery
Pharmaceutical
Biopharma

Date founded

2008

Funding rounds raised

Total raised

$125M

from 10 investors over 10 rounds

I

Immunome, Inc. raised $125M on June 29, 2023

Investors: Woodline Partners LP, Avidity Partners, Redmile Group and Enavate Sciences

I

Immunome, Inc. raised $18M on July 20, 2021

Investors: Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense-JPEO-CBRND

I

Immunome, Inc. raised $13M on July 28, 2020

Investors: united-states-department-of-defense

I

Immunome, Inc. raised $11M on June 16, 2020

Investors: Robin Hood Ventures

I

Immunome, Inc. raised $180K on December 3, 2019

Investors: Robin Hood Ventures

I

Immunome, Inc. raised $7.2M on October 6, 2016

Investors: BioAdvance and Evolution VC Partners

FAQ